Besides the "classical" effects on bone and calcium metabolism, the antiproliferative and redifferentiating capacity of 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 D 3 )-the active form of vitamin D-on several cancer types, including thyroid cancer (cell lines), has been described (Bouillon et al. 2006 ). We and others have shown that 1,25(OH) 2 D 3 and especially superagonistic analogs exert antiproliferative effects in poorly to undifferentiated thyroid cancer cell lines. Combined treatment with other antineoplastic agents has led to additive and even synergistic antiproliferative effects (Dackiw et al. 2004; Clinckspoor et al. 2011 ). 1,25(OH) 2 D 3 exerts its biological activity through binding to the vitamin D receptor (VDR), a member of the nuclear receptor family. VDR polymorphisms and serum 25-OHD 3 levels have been associated with cancer incidence (Giovannucci et al. 2006; Kostner et al. 2009 ). Furthermore, VDR knockout mice exhibit a higher incidence rate of carcinogen-induced lesions compared with their wild-type littermates (Zinser et al. 2005) . These studies highlight the potential role of 1,25(OH) 2 D 3 -VDR signaling in defining sensitivity to carcinogenesis. The metabolism of 1,25(OH) 2 D 3 is tightly regulated through a complex process, involving the vitamin D-activating enzyme CYP27B1, responsible for the final hydroxylation step from 25-OHD 3 toward 1,25(OH) 2 D 3 , and CYP24A1, the key enzyme in the inactivation of 1,25(OH) 2 D 3 . Several studies have focused on the dynamics of VDR, CYP24A1, and CYP27B1 in different cancer tissues such as breast, prostate, colon, and ovary (Segersten et al. 2005; McCarthy et al. 2009; Horvath et al. 2010) , demonstrating altered expression in benign or malignant tumors. The current knowledge on the presence of locally altered vitamin D metabolism in benign and malignant thyroid tissue is limited. The VDR is expressed in normal thyroid tissue (Mangelsdorf 2005) , and increased expression of VDR and CYP27B1 protein compared with normal thyroid tissue was demonstrated in human PTC tissues (Khadzkou et al. 2006) . Furthermore, in a panel of thyroid cancer cell lines, it has been shown that VDR is differentially present, not correlating to the sensitivity of the thyroid cancer cell lines to 1,25(OH) 2 D 3 , contrary to CYP24A1 mRNA levels that were lower in responsive cell lines (Sharma et al. 2010) .
The main purpose of this study was to investigate local vitamin D metabolism in a diverse spectrum of human thyroid tumors, ranging from benign FA to highly malignant ATC, and to study the correlation with markers of proliferation and differentiation and with clinicopathological characteristics.
Materials and Methods

Patients and Tumors
Thyroid tissues were obtained from patients undergoing thyroid surgery at the University Hospitals Leuven in Leuven, Belgium, or at the General Hospital Sint-Jan in Bruges, Belgium. The indication for surgery was based on clinical findings, and snap-frozen thyroid tissues (for RT-PCR analysis) from 64 patients and paraffin-embedded tissues (for immunohistochemistry analysis) from 72 patients were studied. All tumors were histologically classified according to the World Health Organization (WHO) classification. The clinical charts were reviewed and the following patient data were extracted: age at diagnosis, gender, primary tumor diameter, presence of immune cell infiltration, multifocality, and TNM (Edge et al. 2010) for malignancy. Patients with abnormal thyroid function, a toxic nodule, histological diagnosis of underlying autoimmune thyroid disease (Hashimoto or Graves), or nodular hyperplasia at histological examination were excluded, as well as those with partially cystic nodules. The work was approved by the Ethics Committee of the University Hospitals Leuven, and patients gave their written informed consent.
Real-Time Quantitative RT-PCR
Biopsies were taken centrally from the nodule to obtain a pure tumor sample. The samples were immediately snapfrozen in liquid nitrogen and stored at -80°C. In total, 29 FA, 22 FTC, 15 PTC, and 44 normal thyroid tissue samples (from contralateral macroscopically normal lobes) were analyzed. Snap-frozen tumor tissue from only two ATC cases was available, so this subgroup was excluded from the RT-PCR analysis. Total RNA was extracted with TRIzol reagent (Invitrogen; Merelbeke, Belgium). Briefly, 50 to 100 mg thyroid tissue was homogenized and RNA was isolated following phase separation with chloroform, RNA precipitation with isopropanol, RNA wash with 75% ethanol, and eventually RNA redissolving in water. Using Superscript II RT (Invitrogen), 1 µg RNA was reverse transcribed at 42°C for 80 min in the presence of 5 µM oligo(dT) (Roche; Vilvoorde, Belgium). PCR analysis (StepOnePlus; Applied Biosystems, Halle, Belgium) was performed using delta-Ct. Primer and probe sequences (Eurogentec; Seraing, Belgium) for HPRT, VDR, CYP24A1, CYP27B1, NIS, Ki67, and p21 are available upon request. All real-time RT-PCRs were performed with dual-labeled fluorescent Taqman probes. Each experiment was performed with triplicate samples. Expression levels of target genes were compared with HPRT levels in each sample.
Immunohistochemistry
Immunohistochemistry (IHC) for Ki67, VDR, CYP24A1, and CYP27B1 was performed on paraffin-embedded sections from 17 FA, 18 FTC, 20 PTC, 17 ATC, and 31 normal thyroid tissues (see Table 1 ). Deparaffinization, rehydration, and epitope retrieval were performed using PT Link (Dakocytomation; Heverlee, Belgium). After blocking of endogenous peroxidase activity by Envision Flex Peroxidase blocking reagent (Dako), the sections were incubated with the primary antibody for VDR and CYP24A1 (Table 1) . Incubation with the primary antibody against CYP27B1 was preceded by an incubation period with 10% donkey serum. Antibody binding was detected using a second antibody conjugated to a peroxidase-labeled polymer (EnVision; Dako), and peroxidase activity was revealed by diaminobenzidine (DAB) substrate (Dako). Finally, sections were counterstained with hematoxylin and rinsed and mounted with mounting medium (Dako). Kidney tissue was used as a positive control for VDR, CYP24A1, and CYP27B1, whereas omission of the primary antibody was used as a negative control.
The interpretation of the IHC staining was performed by two independent investigators (IC and EH). Ki67 expression was quantified as % stained nuclei/100 cells. For VDR, CYP24A1, and CYP27B1, the following method was used: Staining intensity was ranked either 1 (weak), 2 (modest), or 3 (strong). Staining extension was scored 0 (negative), 1 (<10% of cells stained), 2 (10-50% of cells), and 3 (>50% of cells). The scores for intensity and extension were then multiplied, and the following criterion was applied: Cases with a multiplied score of 4 or higher were considered to have a high level of VDR, CYP24A1, or CYP27B1 expression. In the present study, we have used the H-score for immunostaining, also used by another group (Lopes et al. 2010 ).
Statistical Analysis
Statistical analysis was performed using the software program Statistica (StatSoft; Tulsa, USA). For continuous variables, the unpaired Student's t-test or ANOVA test was performed where appropriate. When the ANOVA test was significant, the Fisher's least significant difference (LSD) multiple-comparison test was applied. For categorical variables, the χ 2 test was used. Pearson's correlation analysis was performed to determine correlations between gene or protein expression. Significance was defined at the 0.05 level.
Results
Increased Local Vitamin D Metabolism in Tumor versus Normal Thyroid Tissue
To characterize the proliferation and differentiation status of the frozen thyroid tissue samples used for RT-PCR analysis, mRNA expression of, respectively the general proliferation marker Ki67 and differentiation marker NIS were studied. As expected, DTC (59% FTC and 41% PTC) was characterized by high Ki67 and very low NIS expression compared with normal thyroid tissue ( Fig. 1; p<0 .02). FA had an intermediary profile characterized by low Ki67 but also low NIS expression.
Further study of expression of genes involved in vitamin D metabolism (Fig. 2) first confirmed the presence of VDR in all subgroups, with a 2-fold increased mean expression in DTC compared with normal thyroid tissue and FA. Mean expression of the 1,25(OH) 2 D 3 -degrading enzyme CYP24A1 was increased in FA. For the mean expression of CYP27B1, capable of local 1,25(OH) 2 D 3 production, we observed a tendency toward higher expression in FA and DTC. Expression of the three main actors of local vitamin D metabolism in thyroid tissue was thus confirmed but with clearly different dynamics in each histological subgroup. No significant difference in mean VDR, CYP24A1, or CYP27B1 mRNA expressions were observed when comparing the DTC subgroups of PTC and FTC (data not shown).
Next, we studied protein expression of VDR, CYP24A1, and CYP27B1 by IHC in identical histological subgroups in a large set of paraffin-embedded tissues, including normal thyroid tissue, FA, and DTC (47% FTC and 53% PTC). Ki67 protein expression was confirmed to be clearly increased in the DTC group (9 ± 0.9% in DTC, 5 ± 2.8% in FA, and 1 ± 0.2% in normal thyroid tissue). As shown in Figure 3A , high VDR expression (multiplied score ≥4; see Materials and Methods) was present in 21% of FA and even in 66% of DTC, but was not detected in normal thyroid tissues. High CYP24A1 and CYP27B1 expressions were also rare in normal tissue (respectively 0% and 2%). However, high CYP24A1 expression was observed in 18% of DTC and even in 33% of FA cases, confirming the mRNA results. High CYP27B1 expression was present in 21% of DTC and 25% of FA. On the other hand, absent VDR, CYP24A1, and CYP27B1 expressions were observed in a lower percentage of FA (respectively 21%, 22%, and 19%) or DTC (3%, 29%, and 13%) compared with normal thyroid tissue (73%, 55%, and 57%). Moreover, within the DTC group, CYP24A1 and CYP27B1 protein expressions were positively correlated (r 2 = 0.43, p<0.05), but no correlation was present with tumor diameter or Ki67 expression. Figure 3B shows representative cases of high VDR, CYP24A1, and CYP27B1 expression in the different subgroups.
Altered Local 1,25(OH) 2 D 3 Metabolism in N 1 versus N 0 PTC Because PTC, by far the most frequent thyroid cancer subtype, frequently locally spreads to the lymph nodes, we further investigated whether differences in local vitamin D metabolism could be observed between PTC with and without lymph node metastases (respectively N 1 and N 0 ). As shown in Figure 4A , mRNA expression of VDR, CYP24A1, and CYP27B1 was lower in PTC N 1 compared with N 0 . Furthermore, PTC N 1 tissues were characterized by higher expression of Ki67 and lower expression of the cell cycle inhibitor p21 mRNA compared with PTC N 0 , indicative of a higher proliferative status (Fig. 4B ). Gene expression of VDR was significantly positively correlated with CYP24A1 (r 2 = 0.62, p<0.05) and CYP27B1 (r 2 = 0.57, p<0.05). Also, the gene expression of the cell cycle inhibitor p21, a well-known target gene of 1,25(OH) 2 D 3 , was positively correlated with VDR and CYP24A1 expressions (r 2 = 0.76 and r 2 = 0.70, respectively; p<0.05).
At the protein level ( Fig. 4C ), 71% of PTC N 1 showed high VDR expression versus 82% of PTC N 0 , and 11% of PTC N 1 showed high CYP24A1 expression versus 18% of PTC N 0 .
On the other hand, negative VDR staining was not observed in any PTC case, and negative CYP24A1 staining was present in a lower percentage of the PTC N 1 cases (22% vs 36%). For CYP27B1, however, more "high" (33% vs 18%) and no "negative" (0% vs 9.0%) protein expression was observed in the PTC N 1 group contrary to the gene expression data. A positive correlation was present between CYP24A1 and CYP27B1 protein expression and was higher than in the more heterogeneous DTC group (r 2 = 0.49, p<0.05).
Compared to DTC, Decreased Vitamin D Metabolism Is Present in ATC, Especially in Case of High Ki67 Expression or Distant Metastasis at Diagnosis
As local vitamin D metabolism was increased in FA and DTC, respectively representing mostly slowly growing benign and malignant thyroid tumor tissue, we finally studied local vitamin D metabolism along with Ki67 expression at the protein level in ATC (17 cases), characterized by aggressive growth (with the presence of distant metastases already at diagnosis in about half of the cases), in comparison with the DTC group (32 cases, 47% FTC and 53% PTC).
ATC was characterized by more than 3-fold increased Ki67 protein expression as compared with DTC (33 ± 3.9% and 9 ± 0.9%, respectively; p<1E -10 ). As shown in Figure 5 , high VDR expression was rare in ATC patients (6%) in contrast to DTC (66%), and the opposite was observed for the percentage of VDR-negative tissues (61% vs 3%). However, the proportion of high CYP24A1 expression was comparable in ATC and DTC (respectively 19% and 18%), whereas high CYP27B1 expression was even slightly higher in ATC compared with DTC (respectively 29% and 21%). But again, proportionally more ATC cases were observed with negative CYP24A1 and CYP27B1 staining (56% and 18%) compared with DTC cases (29% and 13%). A strong positive correlation was present between CYP24A1 and CYP27B1 protein expression (r 2 = 0.80, p<0.05).
Within the ATC group, a different VDR, CYP24A1, and CYP27B1 expression profile was observed in Ki67 "high" (>30%, n=8) versus "low" (≤30%, n=8) cases, especially when observing the percentage of negative staining. As shown in Figure 6A , in the Ki67 "high" group, more cases lost VDR (66.7%), CYP24A1 (63%), and CYP27B1 (25%) protein expressions compared with the Ki67 "low" group (respectively 50%, 43%, and 0%).
Also, when comparing the ATC cases with and without distant metastases at diagnosis (respectively M 1 and M 0 ; for 3 patients, no information on metastatic status was known due to short survival), we observed the tendency toward a further decrease of local vitamin D metabolism in the ATC M 1 group (Fig. 6B ). More specifically, in ATC M 1 tissues, VDR, CYP24A1, and CYP27B1 expressions were negative in a higher proportion (respectively 77.8%, 75.0%, and 22.2%) compared with ATC M 0 tissues (respectively 66.7%, 60.0%, and 16.7%). In Figure 6C , a representative case of a Ki67 low triple-positive and a Ki67 high triplenegative ATC is shown.
Discussion
To investigate the role of 1,25(OH) 2 D 3 in tumorigenesis and its potential as an anticancer treatment, the presence of 1,25(OH) 2 D 3 -regulating proteins has been studied in several malignancies. In the present study, we described and confirmed for the first time the gene and protein expression profiles of VDR, CYP24A1, and CYP27B in a diverse spectrum of human thyroid tumor and normal tissues. Compared with normal thyroid tissue, the three key players involved in the regulation of 1,25(OH) 2 D 3 were present or even enhanced in all cancer subtypes from the thyroid follicular cell origin, suggesting increased local 1,25(OH) 2 D 3 metabolism. However, this enhanced metabolism is partially or completely lost in thyroid cancers metastasizing regionally or at distance. The gene expression mostly, but not always, paralleled the protein expression results.
The presence of VDR in the normal thyroid was previously described (Mangelsdorf 2005) . Later, enhanced VDR and CYP27B1 protein expression was demonstrated in PTC compared with normal human thyroid tissue (Khadzkou et al. 2006) . In our study, we largely extended the investigation to other thyroid tumor subtypes by comparing the expression profile of VDR, CYP24A1, and CYP27B1 in normal thyroid tissue, follicular adenoma, DTC (papillary and follicular subtypes), and ATC.
Both FA and DTC demonstrated enhanced VDR, CYP24A1, and CYP27B1 expressions compared with normal thyroid tissue. Increased vitamin D metabolism has also been described in several other benign and malignant tumors (ovarium, endometrium, colon, breast) (Segersten et al. 2005; Agic et al. 2007; McCarthy et al. 2009; Horvath et al. 2010; Silvagno et al. 2010) , and 1,25(OH) 2 D 3 is known to exert antiproliferative effects on several cancer types (Dackiw et al. 2004; Bouillon et al. 2006; Clinckspoor et al. 2011) . However, other groups reported decreased VDR, CYP24A1, or CYP27B1 expression in cancerous tissue (benign/malignant) compared with normal tissue, such as for breast, colon, and kidney cancer (Lurie et al. 2007; Wada et al. 2009; Blomberg et al. 2010) . The expression of VDR, CYP24A1, and CYP27B1 in tumors might be tissuespecific, and variation even exists between research groups studying the same cancer type. Protein instability, protein half-life, or methodological differences can result in discrepancies between gene and protein expression and variation between research groups (Horvath et al. 2010) .
Comparing well-differentiated malignant thyroid tumors with benign tumors, we observed significantly higher VDR and lower CYP24A1 expressions, whereas CYP27B1 Figure 5 . "High" (left histogram) and "negative" (right histogram) protein expression profiles of vitamin D receptor (VDR), CYP24A1, and CYP27B1 in differentiated thyroid cancer (DTC) and anaplastic thyroid cancer (ATC). VDR protein expression was often lost in ATC compared with DTC. High CYP24A1 and CYP27B1 protein expressions were respectively similar and even slightly higher in ATC compared with DTC, but also more cases of absent CYP24A1 and CYP27B1 staining were found in ATC. *p<0.05.
expression was similar. The high VDR/low CYP24A1 profile in DTC might suggest a stronger antitumor response, increasing local availability of 1,25(OH) 2 D 3 . A pivotal step in cancer progression is metastasis. Because PTC not only represents the most prevalent thyroid cancer but also frequently locally spreads to the lymph nodes, we investigated differential expression of VDR, CYP24A1, and CYP27B1 in primary PTC with or without lymph node metastasis at diagnosis. First, we demonstrated decreased VDR expression in PTC N 1 , which is in line with the findings of Khadzkou et al. (2006) , who observed a decreased VDR protein expression in tumor tissue from lymph node metastasis compared with primary PTC. Together, these data suggest a decreased 1,25(OH) 2 D 3 sensitivity in primary tumors prone to metastasis. On the other hand, the decreased CYP24A1 and increased CYP27B1 protein expressions in the primary PTC lesions with lymph node metastasis might suggest a local antitumor response resulting in elevated local 1,25(OH) 2 D 3 levels. In ATC tissues, VDR expression is lost in the majority of the cases, whereas CYP24A1 and CYP27B1 expressions were comparable with the DTC tissues. Negative staining for VDR, CYP24A1, and CYP27B1 was more pronounced in ATC tissues with high Ki67 expression and Figure 6. "High" (left histogram) and "negative" (right histogram) protein expression profile of vitamin D receptor (VDR), CYP24A1, and CYP27B1 in anaplastic thyroid cancer (ATC) subdivided according to their Ki67 status (low, high) (A) and according to the presence of metastasis (M 0 , M 1 ) at diagnosis (B) and representative photographs of a triple-negative (absent VDR, CYP24A1, and CYP27B1) and triplepositive staining in ATC subdivided according to their Ki67 status (C). (A) More cases of absent VDR, CYP24A1, or CYP27B1 staining were present in ATC cases with a Ki67 "high" status compared with a Ki67 "low" status. (B) Also, more cases of absent VDR, CYP24A1, or CYP27B1 staining were found in ATC M 1 compared with ATC M 0 . (C) Representative photographs of two ATC cases with either a triplepositive or a triple-negative staining for VDR, CYP24A1, and CYP27B1 in, respectively the (i) Ki67 low and (ii) Ki67 high ATC subgroup. Scale bar: 50 µm.
